OPKO Health, Inc. (OPK) financial statements and ratios from SEC XBRL: revenue $606.88M (latest fiscal year), net margin -37.2%, revenue growth 4.3% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $606.88M |
| Net Margin | -37.2% |
| Operating Margin (TTM) | -8.2% |
| Net Debt / EBITDA | -7.5 |
| Revenue Growth (YoY) | 4.3% |
| EPS Growth (YoY) | -94.7% |
| FCF Growth (YoY) | -46.4% |
| EV / EBITDA | 19.0 |
| Price / Book | 0.93 |
| Price / Sales | 1.87 |
| FCF Yield | -12.2% |
| Altman Z-Score | -0.26 (distress) |
| Piotroski F-Score | 3/9 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
| Sector P/E (Healthcare) | 21.7 |
OPK overview · OPK earnings · OPK KPIs · OPK documents · OPK ownership · OPK peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.